33.26
전일 마감가:
$33.46
열려 있는:
$33.49
하루 거래량:
252.12K
Relative Volume:
0.75
시가총액:
$1.35B
수익:
$1.46B
순이익/손실:
$92.09M
주가수익비율:
14.75
EPS:
2.2555
순현금흐름:
$47.29M
1주 성능:
-3.23%
1개월 성능:
-38.37%
6개월 성능:
-20.11%
1년 성능:
+44.48%
Phibro Animal Health Corp Stock (PAHC) Company Profile
명칭
Phibro Animal Health Corp
전화
201-329-7300
주소
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Compare PAHC vs TAK, HLN, TEVA, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
PAHC
Phibro Animal Health Corp
|
33.26 | 1.36B | 1.46B | 92.09M | 47.29M | 2.2555 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.25 | 52.07B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
HLN
Haleon Plc Adr
|
9.29 | 41.28B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.07 | 39.78B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
ZTS
Zoetis Inc
|
81.32 | 33.57B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
UTHR
United Therapeutics Corp
|
568.43 | 24.02B | 3.17B | 1.29B | 1.01B | 27.09 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-15 | 개시 | Citigroup | Neutral |
| 2025-07-07 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-06-16 | 업그레이드 | BNP Paribas Exane | Underperform → Neutral |
| 2024-09-10 | 개시 | JP Morgan | Neutral |
| 2023-12-07 | 개시 | Exane BNP Paribas | Underperform |
| 2022-12-21 | 개시 | ROTH Capital | Buy |
| 2022-07-25 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2022-01-10 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2021-11-18 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-08-05 | 재개 | Credit Suisse | Neutral |
| 2021-07-07 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2020-08-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2020-02-06 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2020-01-28 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2019-09-05 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2019-08-29 | 재확인 | BofA/Merrill | Underperform |
| 2019-06-11 | 개시 | Barclays | Underweight |
| 2019-05-23 | 개시 | Guggenheim | Neutral |
| 2019-05-09 | 업그레이드 | Gabelli & Co | Hold → Buy |
| 2017-08-23 | 재개 | BofA/Merrill | Underperform |
| 2017-06-02 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2016-12-15 | 개시 | Piper Jaffray | Overweight |
| 2016-11-11 | 다운그레이드 | Macquarie | Neutral → Underperform |
| 2016-11-10 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2016-04-11 | 재확인 | Guggenheim | Buy |
| 2016-02-04 | 개시 | Credit Suisse | Outperform |
| 2016-01-15 | 다운그레이드 | Barclays | Overweight → Underweight |
| 2015-09-30 | 개시 | Gabelli & Co | Buy |
| 2015-04-24 | 재확인 | Barclays | Overweight |
| 2015-04-21 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2014-05-06 | 개시 | Barclays | Overweight |
모두보기
Phibro Animal Health Corp 주식(PAHC)의 최신 뉴스
Phibro's CEO transition puts this insider sale in context - AOL.com
Phibro's CEO transition puts this insider sale in context - The Motley Fool
Phibro Animal Health (PAHC) major holder adopts 10b5-1 sale plan - Stock Titan
PAHCPhibro Animal Health Corp Stock Price and Quote - Finviz
PAHC Stock Price, Quote & Chart | PHIBRO ANIMAL HEALTH CORP-A (NASDAQ:PAHC) - ChartMill
Phibro leaders to address investors at Stifel 'Jaws & Paws' in New York - Stock Titan
Phibro Animal Health Corporation to Participate in Stifel Jaws & Paws Conference - Yahoo Finance
PAHC Technical Analysis & Stock Price Forecast - Intellectia AI
Phibro Animal Health Corporation (PAHC) Price Target Cut to $44 by Citi Amid Sector Pressure - Insider Monkey
Phibro Animal Health (PAHC): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Phibro (PAHC) Q1 2026 Earnings: EPS $0.76 Beats EstimatesSocial Buy Zones - Newser
Barclays PLC holds 263,695 shares in Phibro (NASDAQ: PAHC) - Stock Titan
PAHC Maintained by Citigroup -- Price Target Lowered to $44 - GuruFocus
Phibro Animal Health Corp at Bank of America Global Healthcare Conference Transcript - GuruFocus
Phibro Animal Health Sales Grow 10 Percent to 383 Million Dollars - HarianBasis.co
Earnings call transcript: Phibro Animal Health Q3 2026 sees earnings beat, stock tumbles - Investing.com
Phibro Animal Health Corporation (PAHC) Announces Financial Results for Q3 - Insider Monkey
Phibro Animal Health Corp (FRA:PB8) Stock Price & 30 Year Financial Data - GuruFocus
Phibro (PAHC) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term - Yahoo Finance
Q2 2026 Phibro Animal Health Corp Earnings Call Transcript - GuruFocus
Why Phibro Animal Health (PAHC) is a Top Growth Stock for the Long-Term - Yahoo Finance
Down 30.9% in 4 Weeks, Here's Why Phibro (PAHC) Looks Ripe for a Turnaround - Yahoo Finance
Deciphering Phibro (PAHC) International Revenue Trends - Yahoo Finance
Q3 2026 Phibro Animal Health Corp Earnings Call Transcript - GuruFocus
Phibro Sustainable Solutions Platform helps protein producers target greenhouse gas emissions - The National Provisioner
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now? - Yahoo Finance
PAHC Stock Falls Despite Q3 Earnings & Revenue Beat, Margins Rise - Yahoo Finance
Phibro Animal Health CEO Jack Bendheim sells $1.02m in PAHC shares By Investing.com - Investing.com Australia
Phibro Animal Health CEO Jack Bendheim sells $1.02m in PAHC shares - Investing.com
CEO-linked BFI Co. (PAHC) sells 18,608 Phibro shares under plan - Stock Titan
Phibro executives take Bank of America health conference stage May 13 - Stock Titan
Phibro Animal Health Corporation to Participate in Bank of America Securities Health Care Conference - ChartMill
Phibro Q3 FY2026 slides: 10% sales growth amid regulatory headwinds - Investing.com
Earnings call transcript: Phibro Animal Health beats Q3 2026 expectations By Investing.com - Investing.com South Africa
Earnings call transcript: Phibro Animal Health beats Q3 2026 expectations - Investing.com
Phibro Animal Health Reports Strong Q3 2026 Results, Raises Full-Year Guidance with 14% Sales Growth - Minichart
Phibro Animal Health Corp reports results for the quarter ended March 31Earnings Summary - TradingView
MSN Money - MSN
Compared to Estimates, Phibro (PAHC) Q3 Earnings: A Look at Key Metrics - Yahoo Finance
Phibro Animal Health (PAHC) Q3 Earnings and Revenues Surpass Estimates - Yahoo Finance
Phibro: Fiscal Q3 Earnings Snapshot - KTVB
Phibro Animal Health (PAHC) posts 10% Q3 sales growth and raises 2026 guidance - Stock Titan
Phibro Animal Health’s (NASDAQ:PAHC) Q1 CY2026: Beats On Revenue - Yahoo Finance
Animal health demand pushes Phibro sales to $383.5M in Q3 - Stock Titan
Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance - marketscreener.com
Phibro Animal Health (PAHC) lifts sales and profit in Q3 2026 - Stock Titan
Phibro Animal Health earnings on deck: Can MFA momentum hold? By Investing.com - Investing.com South Africa
Phibro Animal Health earnings on deck: Can MFA momentum hold? - Investing.com
Phibro Animal Health Corporation Launches Companywide Sustainable Solutions Platform; Introduces VERRATAIN™ Verified Sustainability Solutions Through Strategic VAXA Technologies Partnership - 01net
Phibro Animal Health Corporation Launches Companywide Sustainable - The National Law Review
Phibro Animal Health Corp (PAHC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):